FDA Approves Botox (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity

DUBLIN, Jan. 22, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has approved Botox (onabotulinumtoxinA) for the treatment of lower limb...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news